Lyniate US dba Rhapsody has filed a notice of an exempt offering of securities to raise $13,217,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Lyniate US dba Rhapsody is raising $13,217,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Erkan Akyuz played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Lyniate US dba Rhapsody
Rhapsody partners with healthcare organizations around the globe delivering its adaptable Interoperability Suite to reliably connect, classify, and clean data. Rhapsody health solutions power the applications and workflows that improve clinical, operational, and financial outcomes today while helping teams respond to and prepare for changes on the horizon. Rhapsody is committed to empowering people throughout the healthcare ecosystem, from specialty clinics to large care networks, from public health to health technology, and everything in between.
To learn more about Lyniate US dba Rhapsody, visit http://www.rhapsody.health/
Contact:
Erkan Akyuz, Chief Executive Officer
857-277-5678
https://www.linkedin.com/company/rhapsodyhealth/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.